| Item Type | Name |
|
Concept
|
Ischemic Attack, Transient
|
|
Academic Article
|
Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
|
|
Academic Article
|
The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.
|
|
Academic Article
|
Effect of clot removal on cerebrovascular contraction after subarachnoid hemorrhage in the monkey: pharmacological study.
|
|
Academic Article
|
Clinical grade, egional cerebral blood flow and angiographical spasm in the monkey after subarachnoid and subdural hemorrhage.
|
|
Academic Article
|
Effects of various intracranial fluids on smooth muscle.
|
|
Academic Article
|
[Cerebral vasospasm. Experimental study].
|
|
Academic Article
|
Scanning electron microscopy of normal and vasospastic monkey cerebrovascular smooth muscle cells.
|
|
Academic Article
|
Intercellular contacts in primate cerebral arteries: acute effects of subarachnoid injection of artificial cerebrospinal fluids, serotonin, and blood.
|
|
Academic Article
|
Effects of erythrocyte lysate of different incubation times on intracellular free calcium in rat basilar artery smooth-muscle cells.
|
|
Academic Article
|
The effect of timing of clot removal on chronic vasospasm in a primate model.
|
|
Academic Article
|
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.
|
|
Academic Article
|
A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model.
|
|
Academic Article
|
Surgical manipulation of primate cerebral arteries in established vasospasm.
|
|
Academic Article
|
Intracellular mechanisms involved in the responses of cerebrovascular smooth-muscle cells to hemoglobin.
|
|
Academic Article
|
Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys.
|
|
Academic Article
|
Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
|
|
Academic Article
|
Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage.
|
|
Academic Article
|
Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
|
|
Academic Article
|
Morphometric analysis of monkey cerebral arteries exposed in vivo to whole blood, oxyhemoglobin, methemoglobin, and bilirubin.
|
|
Academic Article
|
Malondialdehyde, glutathione peroxidase, and superoxide dismutase in cerebrospinal fluid during cerebral vasospasm in monkeys.
|
|
Academic Article
|
Etiology of cerebral vasospasm in primates.
|
|
Academic Article
|
Tyrosine phosphorylation and [Ca2+]i elevation induced by hemolysate in bovine endothelial cells: implications for cerebral vasospasm.
|
|
Academic Article
|
Cerebral vasospasm and free radicals.
|
|
Academic Article
|
Arterial wall changes in cerebral vasospasm.
|
|
Academic Article
|
The effect of graded hypocapnia and hypercapnia on regional cerebral blood flow and cerebral vessel caliber in the rhesus monkey: study of cerebral hemodynamics following subarachnoid hemorrhage and traumatic internal carotid spasm.
|
|
Academic Article
|
Mechanism of cerebral vasospasm following subarachnoid hemorrhage in monkeys.
|
|
Academic Article
|
Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm.
|
|
Academic Article
|
Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
|
|
Academic Article
|
Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
|
|
Academic Article
|
Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage.
|
|
Academic Article
|
Intrathecal fibrinolytic therapy after subarachnoid hemorrhage: dosage study in a primate model and review of the literature.
|
|
Academic Article
|
Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm.
|
|
Academic Article
|
Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
|
|
Academic Article
|
Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model.
|
|
Academic Article
|
Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
|
|
Academic Article
|
Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study.
|
|
Academic Article
|
Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
|
|
Academic Article
|
A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
|
|
Academic Article
|
A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm.
|
|
Academic Article
|
A review of hemoglobin and the pathogenesis of cerebral vasospasm.
|
|
Academic Article
|
U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
|